Academic Title:
Assistant Professor
Pediatrics (office: Pediatric Hem/Onc/BMT)
Publications:
Bhatla T, Wang J, Morrison DJ, Raetz EA, Burke MJ, Brown P, Carroll WL. Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia.
Blood. 2012 May 31;119(22):5201-10. Epub 2012 Apr 11.
Bachanova V, Burke MJ, Yohe S, Cao Q, Sandhu K, Singleton TP, Brunstein CG, Wagner JE, Verneris MR, Weisdorf DJ. Unrelated cord blood transplantation in adult and pediatric acute lymphoblastic leukemia: effect of minimal residual disease on relapse and survival.
Biol Blood Marrow Transplant. 2012 Jun;18(6):963-8. Epub 2012 Mar 16.
Honebrink T, Dayton V, Burke MJ, Larsen K, Cao Q, Brunstein C, Weisdorf D, Miller JS, Wagner JE, Verneris MR. Impact of bone marrow hematogones on umbilical cord blood transplantation outcomes in patients with acute myeloid leukemia.
Biol Blood Marrow Transplant. 2012 Jun;18(6):930-6. Epub 2011 Nov 20.
Mike Burke, B Lindgren, M Verneris. Treatment of relapsed acute lymphoblastic leukemia: Approaches used by pediatric oncologists and bone marrow transplant physicians. Pediatric Blood and Cancer 2011.
Bachanova V et al. (Burke M). Allogeneic Hematopoietic Stem Cell Transplantation Overcomes the Adverse Prognostic Impact of CD20 Expression in Acute Lymphoblastic Leukemia. Blood, February 2011.
Shaw PJ et al. (Burke M). Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors. Blood, November 2010.
Burke MJ, Isaksson Vogel R, Janardan SK, Brunstein C, Smith AR, Miller JS, Weisdorf D, Wagner JE, Verneris MR. Early Lymphocyte Recovery and Outcomes after Umbilical Cord Blood Transplantation (UCBT) for Hematologic Malignancies. Biology of Blood and Marrow Transplantation, August 2010.
Beck J, Cao Q, Trotz B, Weigel B, Smith AR, Verneris MR, Burke MJ.Hematopoietic cell transplantation (HCT) outcomes for early and late bone marrow relapse in pediatric patients with Pre-B cell acute lymphoblastic leukemia (ALL). Bone Marrow Transplantation, July 2010.
Burke MJ. Recent Pharmacological Advances in the Treatment of Acute Lymphoblastic Leukemia. Clinical Medicine: Therapeutics, June 2010.
Verneris MR and Burke MJ. Novel Approaches to Prevent Leukemia Relapse Following Allogeneic Hematopoietic Cell Transplantation. Current Hematologic Malignancy Reports; 2010 Vol 5(3).
Smith AR et al. (Burke MJ). Lower Leukemia Relapse in Pediatric Patients with Pulmonary Cytolytic Thrombi Following Allogeneic Transplant. Blood and Marrow Transplantation; 2010.
M Verneris et al. (M Burke). Reduced Intensity Conditioning Regimens for Allogeneic Transplantation in Children with Acute Lymphoblastic Leukemia. Biology of Blood and Marrow Transplantation; 2010.
Beck J, Tolar J, Burke MJ. Refractory Childhood ITP Post-Allogeneic Bone Marrow Transplant Responsive to Romiplostim. Pediatric Blood and Cancer; September 2009.
MR. Verneris, CG. Brunstein, J Barker, ML. MacMillan1, T DeFor, DH. McKenna, MJ. Burke, BR. Blazar, JS. Miller, PB. McGlave, DJ. Weisdorf, JE. Wagner. Relapse Risk after Umbilical Cord Blood Transplantation: Enhanced Graft versus Leukemia Effect in Recipients of Two Units. Blood; August 2009.
Burke MJ, Cao Q, Trotz B, Weigel B, Kumar A, Smith AR, Verneris MR. Allogeneic Hematopoietic Cell Transplantation (Allogeneic-HCT) for Treatment of Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (ALL). Pediatric Blood and Cancer; August 2009.
Burke MJ, Willert J, Desai S, Kadota R. The Treatment of Pediatric Philadelphia Positive (Ph+) Leukemias in the Imatinib Era. Pediatric Blood and Cancer; May 2009.
Burke MJ, Trotz B, Luo X, Baker KS, Weisdorf DJ, Wagner JE, Verneris MR. Imatinib use pre-or-post allogeneic hematopoietic cell transplantation (Allo-HCT) does not increase cardiac risks in chronic myelogenous leukemia (CML) patients. Bone Marrow Transplantation; February 2009.
Burke MJ, Trotz B, Luo X, Baker KS, Weisdorf DJ, Wagner JE, Verneris MR. Allogenic
Hematopoietic Cell Transplantation (Allo-HCT) for Philadelphia Chromosome Positive Acute
Lymphoblastic Leukemia: Impact of Imatinib on Relapse and Survival. Bone Marrow
Transplantation;January 2009.
Burke MJ, Dayton V. Treatment of a CNS relapse on therapy in Burkitt Lymphoma. Pediatric Blood and Cancer; September 2008.
